At the upcoming 18th edition of the European Multidisciplinary Congress on Urological Cancers (EMUC26), which will take place from 5 to 8 November 2026, leading experts in genito-urological oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology will examine the current practices, identify the best therapies, and review emerging innovations in genitourinary (GU) cancers treatment and management.
At the upcoming 18th edition the European Multidisciplinary Congress on Urological Cancers (EMUC26), which will take place from 5 to 8 November 2026, leading experts in genito-urological oncology, pathology, radiation oncology, radiology, nuclear medicine, and urology will examine the current practices, identify the best therapies, and review emerging innovations in genitourinary (GU) cancers treatment and management.
EMUC26 is a collaboration among the European Society of Radiology (ESR), the European Association of Nuclear Medicine (EANM), the European SocieTy for Radiotherapy and Oncology (ESTRO) and the European Association of Urology (EAU).
The congress will provide essential GU cancers updates, thought-provoking multidisciplinary case discussions, and practical hands-on training courses and workshop. In addition, EMUC26 will also integrate the UROONCO meeting, led by the EAU Section of Oncological Urology, into the scientific programme.
Sessions that will take place in conjunction with EMUC26 will include the EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics, the Meeting of the EAU Section of Urological Imaging, and the Young Academic Urologists (YAU) Meeting.
We look forward to welcoming you in Brussels, Belgium for EMUC26!
Deadlines
| Abstract submission deadline |
1 August 2026, 23:59 CEST |
| Abstract outcome |
Beginning of September |
| Late breaking submission deadline |
1 October 2026, 23:59 CET |
| Late breaking outcome |
Mid-October |
> Absrtract Submission: https://abstracts.emuc.org/
